Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
Sanjoy K Paul, Kerenaftali Klein, Brian L Thorsted, Michael L Wolden, Kamlesh Khunti
Cardiovascular Diabetology | BMC | Published : 2015
The QIMR Berghofer Medical Research Institute is grateful for support from UK-CPRD, Novo Nordisk A/S and an infrastructure research grant from the Australian Government Department of Education's National Collaborative Research Infrastructure Strategy initiative through Therapeutic Innovation Australia. The Leicester Diabetes Research Centre, University of Leicester is grateful for support from the NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC-EM). The interpretation and conclusions contained in this study are those of the authors alone.